- Home
- GDTC vs NOM Comparison
GDTC vs NOM Comparison
Compare GDTC & NOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- NOM
- Stock Information
- Founded
- GDTC 2018
- NOM 1993
- Country
- GDTC Singapore
- NOM United States
- Employees
- GDTC N/A
- NOM N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- NOM Investment Managers
- Sector
- GDTC Health Care
- NOM Finance
- Exchange
- GDTC Nasdaq
- NOM Nasdaq
- Market Cap
- GDTC 28.0M
- NOM 25.0M
- IPO Year
- GDTC 2023
- NOM N/A
- Fundamental
- Price
- GDTC $2.27
- NOM N/A
- Analyst Decision
- GDTC Buy
- NOM
- Analyst Count
- GDTC 1
- NOM 0
- Target Price
- GDTC $5.00
- NOM N/A
- AVG Volume (30 Days)
- GDTC 6.5K
- NOM 6.9K
- Earning Date
- GDTC 01-01-0001
- NOM 01-01-0001
- Dividend Yield
- GDTC N/A
- NOM 3.39%
- EPS Growth
- GDTC N/A
- NOM N/A
- EPS
- GDTC N/A
- NOM N/A
- Revenue
- GDTC $368,838.00
- NOM N/A
- Revenue This Year
- GDTC $5.37
- NOM N/A
- Revenue Next Year
- GDTC N/A
- NOM N/A
- P/E Ratio
- GDTC N/A
- NOM N/A
- Revenue Growth
- GDTC N/A
- NOM N/A
- 52 Week Low
- GDTC $1.20
- NOM $8.52
- 52 Week High
- GDTC $4.05
- NOM $10.48
- Technical
- Relative Strength Index (RSI)
- GDTC 54.58
- NOM 44.21
- Support Level
- GDTC $2.25
- NOM $10.19
- Resistance Level
- GDTC $2.35
- NOM $10.37
- Average True Range (ATR)
- GDTC 0.08
- NOM 0.07
- MACD
- GDTC 0.03
- NOM -0.03
- Stochastic Oscillator
- GDTC 85.29
- NOM 23.80
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About NOM Nuveen Missouri Quality Municipal Income Fund
Nuveen Missouri Quality Municipal Income Fund is a diversified, closed-end management investment company operating in United States. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Missouri state income taxes; its secondary investment objective is the enhancement of portfolio value. The fund invests in municipal securities as well as floating rate securities as well as derivatives such as futures, options and swap contracts to the necessary extent. Nuveen Fund Advisors, LLC acts as an investment adviser of the company.